According to FutureWise analysis, the market for Rabies Antiserum is expected to grow with a CAGR of 3.3% over the forecast period 2024-2032, and reach a market value of US$ 1.6 Billion by 2031.
Rabies antiserum, also known as anti-rabies serum (ARS), is a specialized medical product used in the post-exposure treatment of individuals potentially exposed to the rabies virus. Rabies is a deadly viral infection that affects the central nervous system, and once symptoms appear, it is almost always fatal. As a result, immediate and appropriate medical intervention is crucial after a potential exposure to the virus.
Rabies antiserum is derived from the blood of animals, typically horses or other mammals, hyperimmunized with inactivated rabies virus. This process stimulates the animals' immune systems to produce antibodies against the rabies virus. The blood is then collected, and the serum containing these antibodies is purified and processed for therapeutic use in humans. When administered, the rabies antiserum provides immediate passive immunity against the rabies virus. This means it contains pre-formed antibodies that can immediately neutralize the virus, offering temporary protection while the recipient's immune system mounts a response. The antiserum provides immediate protection, while the rabies vaccine stimulates the recipient's immune system to produce antibodies against the virus for long-term immunity. Rabies antiserum is primarily indicated for individuals who have sustained potentially severe exposures to the rabies virus, such as bites or scratches from animals suspected to be rabid. This treatment is administered as part of a comprehensive post-exposure prophylaxis protocol recommended by healthcare authorities.
FutureWise Market Research has published a report that provides an insightful analysis of Rabies Antiserum Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts' projects that the Rabies Antiserum Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.